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Abstract 
Two complementary instrumental techniques were used, and the data generated was processed 
with advanced numerical tools to investigate the interactions between anti-human apoB-100 
monoclonal antibody (anti-apoB-100 Mab) and apoB-100 containing lipoproteins. Partial 
Filling Affinity Capillary Electrophoresis (PF-ACE) combined with Adsorption Energy 
Distribution (AED) calculations provided information on the heterogeneity of the interactions 
without any a priori model assumptions. The AED calculations evidenced a homogenous 
binding site distribution for the interactions. Quartz Crystal Microbalance (QCM) studies were 
used to evaluate thermodynamics and kinetics of the Low-Density Lipoprotein (LDL) and anti-
apoB-100 Mab interactions. High affinity and selectivity were observed, and the emerging data 
sets were analysed with so called Interaction Maps. In thermodynamic studies, the interaction 
between LDL and anti-apoB-100 Mab was found to be predominantly enthalpy driven. Both 
techniques were also used to study antibody interactions with Intermediate-Density (IDL) and 
Very Low-Density (VLDL) Lipoproteins. By screening affinity constants for IDL-VLDL 
sample in a single injection we were able to distinguish affinity constants for both 
subpopulations using the numerical Interaction Map tool.  
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Introduction 
Variety of techniques are available for evaluation of affinity constant (KA), but they usually 
require either chemical modifications of the reactants, or indirect measurements. These 
techniques include affinity chromatography, radioimmunoassay, enzyme-linked 
immunosorbent assay, X-ray diffraction, nuclear magnetic resonance, mass spectroscopy, 
fluorescence-based methods, and isothermal titration calorimetry. Modern biosensor techniques 
like Quartz Crystal Microbalance (QCM) and surface plasmon resonance, as well as Partial 
Filling Affinity Capillary Electrophoresis (PF-ACE), allow the determination of affinity 
constants without any reactant modifications.  
QCM can measure association and dissociation rate of the molecules, and can be thus utilized 
to study kinetics and thermodynamics at different temperatures. PF-ACE on the other hand, 
with the combination of Adsorption Energy Distribution (AED) calculations, has proven to 
work as a sole method for the investigation of demanding biomolecular interactions [1]. In PF-
ACE the reagents are flowing freely in a solution, as compared to QCM, where immobilization 
of one of the reagents is needed. PF-ACE/AED can be successfully used for elucidation of the 
heterogeneity of interactions, and determination of affinity constant [1-4].  
When biosensors are used for affinity studies, it is relatively easy to generate data, while correct 
data interpretation may be problematic [5]. With poor experimental design and data 
interpretation, it is not unusual that biosensor data does not agree  with the results achieved with 
other techniques [5]. To be able to use a simple binding isotherm with 1:1 interaction model, 
the response of the QCM should reach the plateau, in other words reach equilibrium, before the 
end of the analyte injection, which is called equilibrium analysis. In that case, affinity constants 
obtained with simple 1:1 kinetic model agree with equilibrium analysis, although in case of IgG 
molecule the 1:2 equilibrium is more typical. When all responses of the analyte injection reach 
the equilibrium, the equilibrium analysis can be used, in other cases it is not applicable [5]. 
However, for some biological systems more complex fitting models are required, combined 
with better ways to present the data.  
Low Density Lipoproteins (LDL), Intermediate Density Lipoproteins (IDL) and Very Low-
Density Lipoproteins (VLDL) are the major carriers of triglycerides and cholesterol in human 
circulation [6]. They consist mainly of hydrophobic core containing cholesteryl esters, 
triglycerides, fatty acids and fat-soluble vitamins, and the hydrophilic surface of 
apolipoproteins, phospholipids and un-esterified cholesterol [7]. ApoB-100 is the major 
apolipoprotein in LDL, IDL and VLDL, as well as in Lp(a), a specific LDL- and apo(a)-
containing complex. Main function of apoB-100 is to control the structural integrity of these 
lipoproteins, as well as to control their receptor-mediated removal from the circulation and other 
cellular interactions. The size of LDL particle is approximately 22 nm and can vary between 
80-200 nm for VLDL particles [7]. Due to their complex nature, the lipoproteins have different 
sizes, masses and compositions and these metrics vary from one individual to other. 
Ultracentrifugation separates the lipoprotein species based on their hydrated density differences 
in a heterogeneous mass and size mixture. This affects especially the QCM experiments, since 
kinetics of association and dissociation for LDL particles with smaller particle diameter is 
different compared to that at the larger end of the size distribution. Complex fitting models are 
thus required, and the interactions can be presented as sensograms with model fits or even as 
an Interaction Map, which shows the distribution of association and dissociation constants.  
In this study, mouse anti-human apoB-100 monoclonal antibody (anti-apoB-100 Mab) was used 
to study the interactions between lipoproteins containing apoB-100. PF-ACE/AED was 
exploited as a reference technique to QCM with Interaction Maps. PF-ACE/AED provided the 
information on the heterogeneity of the interaction, and QCM was used to investigate the 
kinetics and thermodynamics at different temperatures. Both techniques were employed to 
determine the affinity constants and they were evaluated in term of applicability for kinetic and 
thermodynamic information. The specificity of anti-human apoB-100 monoclonal antibody 
towards apoB-100 was evaluated by PF-ACE and its interaction with HDL2 including no apoB-
100. 
Material and methods 
Chemicals and materials 
TWEEN 20, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES), ethanolamine, and 
hydrochloric acid (fuming 37%) were purchased from Sigma-Aldrich (St.Louis, MO, USA). 
Phosphoric acid was obtained from Merck (Darmstadt, Germany). Ammonia (25%) was 
purchased from Riedel-de Haën (Seelze, Germany). NaCl was from Fisher Chemicals 
(Loughborough, UK). Dimethyl sulfoxide (DMSO), hydrochloric acid (0.1 - 1.0 M), and 
sodium hydroxide (0.1 - 1.0 M) were obtained from Oy FFChemicals (Yli Ii, Finland). 
Ethylenediaminetetraacetic acid disodium salt dihydrate (Na2EDTA), bovine serum albumin 
(BSA), sodium citrate trihydrate C6H5O7. 3Na 3H2O), and sodium azide (NaN3) were from 
Sigma Chemicals Co. (St. Louis, MO, USA). Gentamycin sulfate (BioReagent, suitable for cell 
culture) was from Lonza (Basel, Switzerland). Sulfo-N-hydroxy-succinimide (S-NHS, 98.0%) 
and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC-HCl, 98.5 %) were 
purchased from Aladin Chemical Regent Company (Shanghai, China). P2VP-b-PEO (Mn,P2VP 
= 3000 g/mol, Mn,PEO = 10000 g/mol, Mw/Mn = 1.13) was purchased from Polymer Source 
(Dorval) (Montreal, QC, Canada). Human blood plasma was obtained from healthy volunteers 
(Finnish Red Cross Blood Service, Helsinki, Finland). LDL, IDL-VLDL and HDL2 were 
provided by Wihuri Institute (Helsinki, Finland). The monoclonal antibody (5.3 mg/ml anti 
apoB-100 code Anti-h ApoB 2101 SPTN-5) was donated by Medix Biochemica Co. Inc 
(Helsinki, Finland). Distilled water was deionized using a Millipore water purification system 
(Millipore, Molsheim, France).  
Instrumentation  
The Attana A100 Quartz Crystal Microbalance (QCM) instrument (Attana AB, Stockholm, 
Sweden) was used for label-free analyses of molecular interactions. LNB-Carboxyl sensor 
chips (Attana AB) providing low non-specific binding were used as the assay surface [2, 3, 8, 
9]. Chamber and sample volumes were 1.25 L and 35 L, respectively. The solvent flow rate 
used was 50 l/min. Temperatures in the kinetic studies were 25-40oC. Attester software was 
used to monitor and record the resonant frequency of the quartz crystal and the frequency shift 
(Δf) of association or dissociation. 
An Agilent 3DCE instrument controlled through an Agilent CE ChemStation (Agilent, 
Waldbronn, Germany) was used for the PF-ACE experiments. The instrument was equipped 
with a diode array detector and a temperature controlling unit regulated by air during the 
analyses. Detection was done with UV at the 200 nm wavelength. Temperature of the electrolyte 
and sample vial unit in the CE was controlled by water perfusion from an external water bath 
(MGW Lauda K2, Lauda-Köningshofen, Germany). Temperature in the separation and the vial 
units was 37oC.  
Fused-silica capillaries (i.d. 50 μm) used in the study were purchased from Optronis GmbH, 
Kehl, Germany. In all the experiments, their efficient (Leff) and the total lengths (Ltot) were 30.0 
cm and 38.5 cm, respectively. A WTW pH 7110 pH meter (WTW GmbH, Weilheim, Germany) 
was used to control the pH of the electrolyte solutions (BGE). The combination electrode were 
calibrated with buffer solutions (Fisher Scientific, UK) of pH 4 (phthalate, pH 3.98 at 20°C), 
pH 7 (phosphate, pH 7.02 at 20°C), and pH 10 (borate, pH 9.99 at 20°C).  
Ultracentrifugation was made using Beckman Optima TL Table-Top ultracentrifuge (Beckman 
Coulter, Brea, CA).  
Preparation of buffers and solutions 
Phosphate buffer (I = 20 mM) used in CE and QCM experiments was prepared by adding 485 
μl of phosphoric acid (85%) and dissolving it with 14.16 ml of 1.0 M NaOH to 900 ml of Milli-
Q water. The pH of the solution was first adjusted to 7.4 with 1.0 M HCl and then filled to the 
final volume of 1000 ml with Milli-Q water. To calculate the ionic strength of the buffer, pKa,2 
of 7.2 [10] was used for phosphoric acid. 
In isolation of the biological compounds with dialysis studies the solution was phosphate-
buffered saline (PBS, pH 7.4). It was prepared following the standard procedure. 1M 
ethanolamine solution (pH 9.0) was prepared by adjusting the pH with hydrochloric acid 
(fuming 37%). Preparation of 0.28 M ammonium hydroxide (pH 11.5) was done by dissolving 
1.13 ml of 25% ammonia into the 50 ml of Milli-Q water. 
Phosphate buffer (I = 20 mM) was used to dilute anti-apoB-100 Mab (100 µg/ml) for using the 
antibody in amine coupling on the LNB-Carboxyl layer on the biosensor chips. The buffer (10 
mM HEPES, 150 mM NaCl, 0.005% Tween 20, pH 7.4) for the immobilization was prepared 
by dissolving 1.19 g of HEPES with 4.38 g of NaCl and 0.25 ml of 10 % Tween 20 in 400 ml 
of Milli-Q water, followed by adjustment to pH 7.4 with 1.0 M NaOH. Final volume of the 
immobilization buffer was adjusted to 500 ml with MilliQ water. Activation reagents, 0.4 M 
EDC and 0.1 M S-NHS, were both dissolved in Milli-Q water before mixing. LDL and IDL-
VLDL samples (3-110 µg/ml) used in QCM experiments were diluted in the phosphate buffer 
(I = 20 mM). Regeneration solution for QCM experiments was prepared by diluting 25 % 
ammonia in MilliQ water to obtain 0.28 M ammonium hydroxide pH 11.5. All stock solutions 
were stored at +4oC and -20oC. 
Production of monoclonal antibody 
Monoclonal antibody was produced in vitro using mouse hybridoma production technology. 
Splenocytes were collected from the immunized mouse and the highest antisera titer were fused 
with myeloma cells [11]. Mice were immunized with highly purified human LDL. In vitro 
cultured hybridoma cells secreted specific anti-human apoB-100 monoclonal antibody (IgG1 
class) in culture medium. The antibody was purified by protein affinity chromatography. Clear 
solution of purified IgG1 subclass was made in 50 mM Na-citrate, pH 6.0, 0.9% NaCl 
containing 0.095 % NaN3 as anti-bacterial agent and stored at +4oC. Before use the solution 
was dialyzed against phosphate-buffered saline (PBS, pH 7.4). Epitope in apoB-100 
polypeptide chain recognized by this established anti-apoB-100 Mab is not known.  
Isolation and characterization of Low Density Lipoprotein (LDL) 
Human LDL (d = 1.019–1.050 g/ml) was isolated by sequential ultracentrifugation in the 
presence of 3 mmol/l Na2EDTA [12, 13]. First, EDTA and 100 µg/ml gentamycin sulfate were 
added to the plasma sample and the density was adjusted to 1.019 with KBr. Then, the plasma 
sample was centrifuged at 40 000 rpm (rotor 50.2 Ti, gmax 302 000) at +4°C for 24 h. The IDL-
VLDL fraction was collected from the top and the density of the remaining plasma was set to 
1.050 g/ml with KBr. The density-adjusted plasma was centrifuged at 40 000 rpm for 72 h and 
the plasma for further steps was collected on the top of the solution. The collected solution was 
re-centrifuged at a density of 1.063 g/ml for 24 h, collected and dialyzed extensively against 
150 mM NaCl – 1 mM EDTA (pH 7.4) followed by dialysis against phosphate-buffered saline 
(PBS, pH 7.4) which was used for CE analyses. The amounts of LDL and VLDL-IDL are 
expressed in terms of the protein concentration. The concentrations including that of anti-apoB-
100 Mab were determined by the method of Lowry et al. [14] or by BCA protein assay kit 
(Pierce, Rockford, IL) using bovine serum albumin as the standard. Molar concentrations of 
LDL, IDL-VLDL were calculated using molecular weight of apoB-100 (512 kDa). For anti-
apoB-100 Mab, molecular weight of 155 kDa was used. 
Isolation of high-density lipoprotein (HDL2)  
HDL2 was isolated from serum and plasma samples by sequential ultracentrifugation and KBr 
was used for density adjustment. After the first isolation of apoB-containing lipoproteins at d = 
1.063 g/mL (5°C, 3h, 500,000 x g), the infranatant fraction was adjusted to density 1.125 g/mL 
with solid KBr and then centrifuged (5°C, 18h, 500,000 x g). The HDL2 was obtained in top 
fraction. The purity of the isolated HDL2 was checked with FPLC size-exclusion 
chromatography. The isolated HDL2 was dialyzed against phosphate-buffered saline (PBS, pH 
7.4) and stored at -80°C before analysis.  
Sample preparation 
The solutions of anti-apoB-100 Mab (0.0002 - 0.1 mg/ml) used as binding ligand in PF-ACE 
experiments were diluted in phosphate buffer (I = 20 mM). In addition, LDL (0.075 mg/ml), 
IDL-VLDL (0.036 mg/ml), and HDL2 (0.2 mg/ml) used as the antigens in PF-ACE were diluted 
in phosphate buffer (I = 20 mM). DMSO (1% v/v) was dissolved in Milli-Q water. 
Immobilization solution was prepared in the same manner as mentioned above from phosphate, 
but pH was adjusted to 6.4 with 1.0 M HCl.  
Immobilization of anti-apoB-100 Mab on LNB-Carboxyl sensor chip  
Immobilization of anti-apoB-100 Mab was done with amine coupling procedure according to 
manufacturer’s recommendations with slight modifications. Prior to the immobilization the 
LNB-Carboxyl sensor chip was pre-wetted ex-situ with 20 µl of Milli-Q water and thereafter 
inserted into the instrument and left to stabilize. The immobilization was performed with the 
analysis buffer (10 mM HEPES, 150 mM NaCl, 0.005% Tween 20, pH 7.4) at the flow rate of 
10 µl/min under 25oC. To activate the surface, freshly mixed 0.4 M EDC and 0.1 M S-NHS 
(1:1, v/v) was injected using automated C-Fast software for 5 minutes. The surface activation 
was done only once. The amine coupling of anti-apoB-100 Mab (100 µg/ml in phosphate buffer; 
pH 6.4) was carried out by injecting the solution twice for 5 minutes. Finally, the remaining 
carboxyl groups were deactivated with two injections (5 minutes each) of 1 M ethanolamine 
solution (pH 9.0). 
QCM interaction studies at different temperatures 
LDL and IDL-VLDL experiments were all carried out at flow rate of 50 µl / min with injection 
volume of 35 µl. LDL and anti-apoB-100 Mab interactions were studied at temperatures of 
25.0, 34.0, 35.0, 36.0, 37.0, 38.0, 39.0, and 40.0oC. IDL-VLDL and anti-apoB-100 Mab 
interactions were studied at 37.0oC. LDL and IDL-VLDL concentrations ranged from 3 to 110 
µg/ml. Three repetitions were made to verify the precision of the data. In this study, we assume 
that the Sauerbrey relation is valid and that the QCM frequency shifts are proportional to the 
adsorbed amount of solute [15]. 
QCM analysis of anti-apoB-100 Mab – lipoprotein interactions 
The measurements started after the waiting period of 20 minutes to stabilize the resonant 
frequency. LDL and IDL-VLDL samples were injected to the surface of chips, monitoring first 
the association for 50 seconds and then the dissociation for 500 seconds. After each association 
and dissociation cycle, the biosensor chip was regenerated with injection of 0.28 M ammonium 
hydroxide (pH 11.5) and re-equilibrated with the analysis buffer. 
Estimation of kinetic rate constants 
Estimation of kinetic rate constants is an inverse problem, i.e., a problem where given the 
response of the system we want to estimate system parameters. Here we are going to estimate 
system parameter distributions rather than a finite set of system parameters values.  
In general, assuming that the total measured response, Rtot, of a system can be written as a linear 
combination of some individual responses r (e.g. Rtot is the sum of the responses for all one-to-
one interactions for biosensors) we have that, 
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where x is the independent variable(s) for the system, e.g. the analysis time, p is the system 
parameter(s), e.g. rate constants, and a is a constant. If we let n in Eq. (1) → ∞ we get that, 
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where Ωm is the considered system parameter space. Eq. (2) is known as an Inhomogeneous 
Fredholm Integral Equation of the first kind with kernel R and our goal is to estimate the 
function a(p). Assume that we have measured the total response Rtot(x) for the system, and 
discretize Eq. (2), the problem of estimating a(p) can be written as a linear system of the form, 
    tot( , ) , M p x a p R x   (3) 
where M is a matrix and a, Rtot are discrete sample vectors of a(p) and Rtot(x), respectively. Eq. 
(3) is usually an ill-conditioned over- or underdetermined linear system and often the condition 
a ≥ 0 is imposed. In order to get reasonable solutions to Eq. (3) regularization is often used, the 
most common one is Tikhonov regularization where we instead of Eq. (3) solve the following 
linear system, 
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where Γ is a regularization matrix (usually an identity or Laplacian matrix) and λ is a 
regularization parameter. 
For biosensors the kernel R in Eq. (2) can be written, 
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where t (analysis time) and C (analyte concentration) are the independent variables and ka, 
(association rate constant) and kd (disassociation rate constant) are non-negative system 
parameters. Above t0 is the time when the injection of the analyte begins and tinj is the injection 
time. The solution a(ka, kd) to Eq. (2) with the kernel in Eq. (5) is known as an Interaction Map 
[16, 17], see Figs. 3 and 5. The Interaction Maps in this study were calculated using the 
TraceDrawer software from Ridgeview Instruments AB, Sweden. 
Capillary electrophoresis coating procedure 
Unfavorable adsorption of lipoproteins on the negatively charged fused-silica capillary was 
diminished by coating the capillary inner wall with quaternized double-hydrophilic poly(N-
methyl-2-vinyl pyridinium iodide-block-ethylene oxide) (P2QVP-b-PEO) diblock copolymer 
[18]. P2QVP-b-PEO (0.1 mg/ml) was dissolved in Milli-Q water. Coating procedure was 
slightly modified from previous studies [1, 18]. First an uncoated fused-silica capillary was 
pretreated by flushing for 15 min, 10 min, and 10 min with 0.1 M NaOH, Milli-Q water, and 
phosphate buffer (pH 7.4, I = 20 mM) at the pressure of 940 mbar. Then the capillary was 
flushed for 20 min, 10 min, 25 min, and 5 min with 1 M HCl, 0.1 M HCl, Milli-Q water, and 
the pH 7.4 phosphate buffer, respectively, at the pressure of 940 mbar. After pretreatment, the 
voltage of +15 kV was applied for 5 min. The P2QVP-b-PEO coating solution was then applied 
for 40 min and left for 30 min to react with the silanol groups on the capillary surface. Excess 
copolymer solution in phosphate buffer was then rinsed by flushing through the capillary for 
60 min at the pressure of 940 mbar. The coating procedure with the polymer solution was 
repeated twice to ensure the best possible stability of the wall coating. The whole procedure 
was conducted at 37.0oC. To ensure the success of the coating, electro-osmotic flow (EOF) 
mobility was measured using DMSO with the Williams and Vigh method [19]. The stability of 
the mobility value was controlled also during the kinetic studies. It was to be at the level of 10-
9 – 10-10 m2V-1s-1. 
Partial filling procedure 
Partial filling (PF) procedure in CE was slightly modified from our previous studies [1-4, 20]. 
Briefly, negatively charged analytes were hydrodynamically introduced to the coated capillary. 
First, slightly negative anti-apoB-100 Mab was introduced in the concentration range of 0.0002 
to 0.1 mg/ml for 3 s, followed by injection of the more negative lipoproteins at 50 mbar pressure 
[18]. The lipoprotein concentrations were different in the antibody-antigen reactions. LDL 
(0.075 mg/ml) was introduced for 2s, IDL-VLDL (0.0036 mg/ml) for 8s, and HDL2 (0.20 
mg/ml) for 2s at 50 mbar. When the voltage of -25 kV was applied and detector was in the 
cathode end, more anionic lipoproteins reached anti-apoB-100 Mab and formed the LDL - anti-
apoB-100 Mab complex and the IDL-anti-apoB-100 Mab and the VLDL - anti-apoB-100 Mab 
complexes. HDL2 lacking apoB-100 was used as a control to test the specificity of the anti-
apoB-100 Mab. The detection was performed at the wavelength 200 nm. Before each run, the 
capillary was rinsed for 2 min with the phosphate buffer (pH 7.4). All the experiments were 
conducted at 37.0oC. After every second run, the EOF mobility was measured to control the 
stability of the coating.  
Determination of affinity constants with PF-ACE 
To determine the affinity constants for complexes between LDL, ILD-VLDL and anti-apoB-
100 Mab, the AED calculations were used. First, the LDL or IDL-VLDL fractions, bound to 
anti-apoB-100 Mab, were established as a function of anti-apoB-100 Mab concentrations. The 
interactions were studied by injecting anti-apoB-100 Mab with increasing concentrations, 
followed by a constant LDL or IDL-VLDL concentration and volume. Then the voltage was 
applied and LDL or IDL-VLDL having more charges than anti-apoB-100 Mab reached the anti-
apoB-100 Mab and interacted with it. The average mobility of the antibody-antigen complex 
can be described with following equation [21]: 
 µA = 𝛩fµf + 𝛩bµb (6) 
where Θf and Θb are the free and bound fractions of LDL or IDL-VLDL, respectively, and μf 
and μb are the mobilities of free and bound LDL or IDL-VLDL to anti-apoB-100 Mab, and μA 
is the average mobility of the complex. Since Θf + Θb = 1, equation of adsorbed fraction can be 
presented as: 
 𝛩b =
µA−µf
µb−µf
 (7) 
The mobilities of the adsorbed and free fractions were investigated with exponential and linear 
fitting, respectively. At the lower end of the concentration range, electrophoretic mobility 
decreased linearly towards the minimum value, where LDL or IDL-VLDL was in free form. At 
the high concentration end, where LDL or IDL-VLDL was completely bound to anti-apoB-100 
Mab, electrophoretic mobility reached the maximum value. 
Adsorption isotherms and adsorption energy distribution 
Adsorption isotherms describe the fraction of analyte adsorbed or in free solution at equilibrium 
to a constant and specific temperature [22, 23]. Langmuir model describes adsorption to a 
limited number of equal adsorption sites can be expressed as: 
 A
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  (8) 
where C is the analyte concertation in the running buffer,   is fractional surface coverage and 
KA is the association equilibrium constant. As described above the Langmuir model can only 
describe one type of interaction. However, many adsorption processes are a result of several 
different type of interactions such as ion-ion, hydrophobic interactions etc. One simple way to 
model heterogeneous adsorption process is to use the bi-Langmuir adsorption isotherm. The Bi-
Langmuir model is just the sum of two Langmuir models, and can be presented as: 
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Here, indices 1 and 2 denote the first and second adsorption sites, respectively.  S,i is the 
saturation fraction for the i:th site. Observe that  S,1 +  S,2 = 1. One other way to describe 
heterogeneous adsorption is to expanding the Langmuir adsorption isotherm model into a 
continuous distribution of independent homogeneous sites across a certain range of adsorption 
energies as done below [3, 24]: 
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Here, θ(C, KA) is the local adsorption model, and f(ln KA) is the adsorption energy distribution 
(AED). KA,min and KA,max are determined from the inverse maximum and minimum sample 
concentration used in the CE experiments. In this study, the AED is solved using the expectation 
maximization method, where the integral equation is iteratively solved [25]. Observe that both 
the AED in Eq. (10) and Interaction Maps are Inhomogeneous Fredholm Integral Equations of 
the first kind with kernel θ(C, KA), see Eq. (2). 
Results and discussion 
Interactions between anti-apoB-100 Mab and lipoprotein were studied with PF-ACE/AED and 
QCM with Interaction Map. In PF-ACE studies, anti-apoB-100 Mab was freely floating in 
background electrolyte solution under physiological buffer conditions so in that sense the 
system resembles conditions in general blood circulation. However, in the QCM studies were 
carried out under the same conditions where anti-apoB-100 Mab was immobilized covalently 
onto the chip surface. Due to its high reliability, the QCM system allowed to study the kinetics 
and the thermodynamics of the antibody-antigen interactions.  
Partial filling affinity capillary electrophoresis 
Adsorption isotherms for the interactions between LDL, IDL-VLDL and anti-apoB-100 Mab 
were determined at 37oC by PF-ACE. To avoid non-specific adsorption of lipoproteins onto the 
negatively charged fused silica capillary surface, the capillary inner wall was coated with 
P2QVP-b-PEO diblock copolymer [18]. The coating was freshly prepared for each interaction 
study. EOF mobilities of every second run were monitored using Williams and Vigh method 
[19] to correct the migration times of the analytes. Since lipoproteins have higher mobilities 
due to their negative charges than the anti-apoB-100 Mab that is almost immobile at pH 7.4 (pI 
7.0), they were hydrodynamically introduced into the capillary after anti-apoB-100 Mab, and 
they reached anti-apoB-100 Mab in the capillary resulting in quick antibody-antigen 
immunocomplex formation. As expected no complex was formed between anti-apoB-100 Mab 
and HDL2 lacking apoB-100. This confirmed the specific nature of anti-apoB-100 Mab towards 
apoB-100 containing lipoproteins, leading to migration time changes of apoB-100 Mab 
complexes with LDL and IDL-VLDL (Fig.1). We also observed that system peaks in the 
beginning of the electropherograms were caused by anionic ions caused by bromide ion of KBr 
that was used to adjust density of the lipoproteins in the ultracentrifugation. This was eliminated 
by replacing the ultracentrifugation medium with PBS solution resulting in bromide free broad 
IDL-VLDL peak (Fig. 1 B). Electropherograms of Fig. 1 provided the raw adsorption isotherm 
data for LDL and IDL-VLDL, see Eq. (7). The affinity constants were calculated from 
Scatchard plot analysis and heterogeneity of the adsorption isotherm models were analyzed 
with AED calculations using the median values of the adsorption data for LDL, IDL-VLDL and 
anti-apoB-100 Mab systems at 37oC. Fig. 2 demonstrates a single site model adsorption. Table 
1 shows the affinity constant for LDL and anti-apoB-100 Mab interaction obtained by PF-
ACE/AED, while Table 3 lists the affinity constants for IDL-VLDL and anti-apoB-100 Mab 
interaction. A slightly higher affinity constant (KA = (4.94 ± 1.33)∙107 M-1, log KA = 7.69) was 
measured for interaction between IDL-VLDL and anti-apoB-100 Mab compared to that 
between LDL and anti-apoB-100 Mab (KA = (2.54 ± 0.88)∙107 M-1, log KA = 7.41).  
Effect of temperature on affinity and kinetics studied by QCM 
To study the effect of temperature on the affinity and kinetics of the interactions between LDL 
and anti-apoB-100 Mab by QCM, the following temperatures were used 25.0, 34.0, 35.0, 36.0, 
37.0, 38.0, 39.0, and 40.0oC. The data points were determined three times at specified 
temperature. Fig. 3 shows selected sensorgrams, along with model fits for association and 
dissociation, as well as Interaction Maps at 37oC. The response and representative QCM 
sensograms at all the concentrations employed for LDL can be found in Figs. S1 and S2. The 
kinetics and affinity parameters at 37oC were estimated from the Interaction Map peak using 
Ridgeview software and thereby kinetic parameters, such as association rate constant (8.61·105 
M−1 s−1) and dissociation rate constant (9.55·10-3 s−1) were obtained. Affinity constant (KA = 
9.02∙107 M-1, log KA = 7.96) for LDL and anti-apoB-100 Mab was calculated from the ratio of 
binding rate constants KA = 1/(kd/ka). The kinetics and affinity parameters for LDL and anti-
apoB-100 Mab interactions at other temperatures were evaluated following the same procedure. 
From the data in Table 1 measured from the QCM experiments it can be seen that while the 
association rate constant stayed relatively unchanged when going from 25 to 40oC, the 
dissociation rate constant increased 10-fold, resulting also in 10-fold loss in affinity from 
4.68·108 to 4.57·107 M-1 (log KA = 8.67 to log KA = 7.66).  
Thermodynamic studies carried out by quartz crystalline microbalance  
In this study, the QCM sensor was used to provide thermodynamic parameters, which can be 
used to elucidate if LDL and anti-apoB-100 Mab interaction is enthalpy or entropy driven. Data 
received from Interaction Maps (Table 1) were used. When enthalpy change is not temperature 
dependent van’t Hoff plot (lnK vs 1/T) results in a linear slope -∆H/R [26], and thermodynamic 
parameters can be obtained from the following equation: 
 ln𝐾 =
−∆𝐻
𝑅𝑇
+
∆𝑆
𝑅
 (11) 
where K is association constant, ∆𝑆 is change in entropy, ∆H is enthalpy change, T is 
temperature, and R being the gas constant 8.314 JK-1 mol-1.  
Fig. 4 shows van’t Hoff plot of lnK as a function of 1/T, which appears to be nearly linear, 
indicating that enthalpy change (∆H) was temperature independent. The results (Table 2) 
calculated from the van’t Hoff plot indicate that interaction between LDL and anti-apoB-100 
Mab is predominantly enthalpy driven, resulting in the following thermodynamic parameters: 
∆H = -116.7 kJ mol−1, and ∆S = -225.0 J K−1 mol−1. 
Study of IDL-VLDL and anti-apoB-100 Mab interactions 
QCM was also used to elucidate the interactions at physiological temperature 37oC between 
anti-apoB-100 Mab and IDL-VLDL that were co-isolated without separation by 
ultracentrifugation. Similarly to LDL studies, each of the data point was determined three times. 
Fig. 5 shows selected sensograms, along with model fits for association and dissociation, as 
well as Interaction Maps at 37oC. The response and representative QCM sensograms at all the 
concentrations used for IDL-VLDL can be found in Figs. S3 and S4. The kinetics and affinity 
parameters at 37oC were estimated from the Interaction Map peak using TraceDrawer software. 
From the Interaction Map (Fig. 5) it is evident that the interactions between anti-apoB-100 Mab 
and IDL-VLDL produced two peaks that represented binding-like processes with distinct 
kinetic parameters. Association rate constant for site 1, which represents the highest peak with 
a weight of 64% was 5.54·105 M−1s−1, and it had a dissociation rate constant of 5.54·10-3 s−1. 
Affinity constant for site 1 (KA = 1.00∙108 M-1, log KA = 8.00) was calculated from the ratio of 
binding rate constants KA = 1/(kd/ka). Association rate constant for site 2 represents the smaller 
peak (Fig. 5) with a weight of 22% was 5.15·104 M−1s−1, and it had a dissociation rate constant 
of 8.07·10-4 s−1. Affinity constant for site 2 (KA = 6.38∙107 M-1, log KA = 7.80) was also 
calculated from the ratio of binding rate constants KA = 1/(kd/ka). Results for IDL-VLDL and 
anti apoB-100 Mab interaction study are shown in Table 3.  
QCM study of LDL, IDL-VLDL and anti-apoB-100 Mab interactions at 37oC gave slightly 
higher affinity for IDL-VLDL (log KA = 8.00, site 1) than for LDL (log KA = 7.96), supported 
by PF-ACE/AED studies (Fig. 2, Tables 1 and 3). Site 2 (log KA = 7.80) had on the other hand 
lower affinity than LDL. The association rate constant (5.54·105 M−1s−1) for interaction site 1 
for IDL-VLDL was slightly lower to that of LDL (8.61·105 M−1s−1), and even lower for site 2 
(5.15·104 M−1 s−1), most probably due to higher mass of both IDL and VLDL compared to LDL. 
The dissociation rate constant for LDL was 9.55·10-3 s−1, while for IDL-VLDL the constants 
were 5.54·10-3 s−1 for site 1, and 8.07·10-4 s−1 for site 2. The results prove that slower 
dissociation was again caused by larger mass of both IDL and VLDL compared to that of LDL. 
This was also noticed by Guha et al., who concluded that structural stability of LDL and VLDL 
is determined by kinetic barriers, resulting in decelerated interconversion among lipoprotein 
subclasses and classes [27]. IDL also forms a minor component in the isolated IDL-VLDL 
fraction, and due to the different masses and overall compositions, the IDL and VLDL 
interacted with anti-apoB-100 Mab with different kinetics resulting in two peaks in the 
Interaction Map (Fig. 5). Isolated LDL sample resulted on the other hand demonstrated only 
one peak in the Interaction Map (cf. Fig. 3).  
Conclusions 
Partial filling affinity capillary electrophoresis combined with adsorption energy distribution 
calculations and quartz crystal microbalance with Interaction Maps were successfully utilized 
to study kinetics and thermodynamics in the anti-apoB-100 Mab and apoB-100 containing 
lipoprotein complex formation. Thermodynamic studies demonstrated that LDL and anti-apoB-
100 Mab interaction was predominantly enthalpy-driven. Interaction Maps that visualize in an 
excellent way the association and dissociation phenomena, were used to study the kinetics of 
the LDL and anti-apoB-100 Mab antigen-antibody complex formation at different temperatures. 
It was found that while association rate constant was not affected much by changes in 
temperature, the dissociation rate constant increased 10-folds from 25oC to 40oC. Interaction 
between combined IDL-VLDL fraction and anti-apoB-100 Mab was also studied and 
Interaction Maps enabled to distinguish two distinct kinetic parameters for IDL-VLDL fraction 
in a single run. QCM combined with Interaction Map calculations has a great potential to study 
selectively biomolecular interactions of biological sample mixtures. PF-ACE with AED 
confirmed that the interaction between anti-apoB-100 Mab and apoB-100 containing 
lipoproteins was homogenous with a single site adsorption model. The affinity data obtained 
with QCM and PF-ACE agreed very well with each other, thus proving proof for their reliable 
use in biomolecular interaction studies. 
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FIGURES  
 
Figure 1. Partial filling affinity capillary electrophoresis electropherograms as a function of 
concentration of anti apoB-100 Mab interacting with (A) LDL; (B) IDL-VLDL; and (C) HDL2. 
Running conditions: -25 kV, injection time of LDL 2 sec, IDL-VLDL 8 sec, and HDL2 2 sec, 
all at 50 mbar, injection time of anti apoB-100 Mab was 3 sec at 50 mbar, 37oC, Ltot 38.5, Ldet 
30 cm, UV detection 200 nm, BGE phosphate buffer (pH 7.4, I 20 mM), concentrations of LDL 
0.075 mg/ml, IDL-VLDL 0.036 mg/ml, and HDL2 0.2 mg/ml, and anti-apoB-100 Mab 
concentration ranging from 0.00 to 0.10 mg/ml.  
 
Figure 2. AED calculations for LDL, IDL-VLDL and anti-apoB-100 Mab systems at 37oC. 
  
  
Figure 3. Interactions between LDL and anti-apoB-100 Mab at 37oC presented (A) and (B) as  
Interaction Maps, (C) as sensograms and model fits for association, and (D) as sensograms and 
model fits for dissociation. The dotted curves represent the model fitted sensograms and solid 
curves those obtained from the experimental data. 
  
 Figure 4. Van’t Hoff plot for the interactions between LDL and anti-apoB-100 Mab. 
  
 Figure 5. Interactions between IDL-VLDL and anti-apoB-100 Mab at 37oC presented (A) and 
(B) as  Interaction Maps, (C) as sensograms and model fits for association, and (D) as 
sensograms and model fits for dissociation. The dotted curves represent the model fitted 
sensograms and solid curves those obtained from the experimental data.   
 
 
 
 
  
TABLES 
Table 1. Effects of temperature- on kinetics and affinity data between anti-apoB-100 Mab and 
LDL obtained by QCM using Interaction Maps, and by PF-ACE using AED. 
System Temp. 
[oC] 
KA  
[M-1] 
log KA KD  
[nM] 
ka  
[M-1s-1] 
kd  
[s-1] 
QCM 25 4.68·108 8.67 2.14 8.13·105 1.74·10-3 
34 1.45·108 8.16 6.92 7.76·105 5.37·10-3 
35 1.23·108 8.09 8.13 7.94·105 6.46·10-3 
36 7.24·107 7.86 13.80 6.92·105 9.55·10-3 
37 9.02·107 7.96 11.09 8.61·105 9.55·10-3 
38 7.41·107 7.87 13.49 9.12·105 1.23·10-2 
39 6.03·107 7.78 16.60 8.51·105 1.41·10-2 
40 4.57·107 7.66 21.88 8.32·105 1.82·10-2 
CE 37 2.54·107 7.41 39.37 ND ND 
ND, not determined. KA, affinity constant. KD, dissociation constant. ka, association rate 
constant. kd, dissociation rate constant.  
Table 2. The effect of temperature on the derived thermodynamic state functions for the 
interaction of LDL and anti-apoB-100 Mab measured by QCM. 
Temp. [oC] ΔGo  
[kJ mol-1] 
ΔHo  
[kJ mol-1] 
ΔSo  
[J·K-1 mol-1 ] 
25 -49.5 -116.7 -225.0 
34 -48.0 -116.7 -225.0 
35 -47.7 -116.7 -225.0 
36 -46.5 -116.7 -225.0 
37 -47.2 -116.7 -225.0 
38 -46.9 -116.7 -225.0 
39 -46.5 -116.7 -225.0 
40 -45.9 -116.7 -225.0 
  
 Table 3. Kinetics and affinity data between anti-apoB-100 Mab and IDL-VLDL obtained by 
QCM using Interaction Maps, and PF-ACE using AED. 
ND, not determined. Subscripts 1 and 2, represent sites 1 and 2.  KA, affinity constant. KD, 
dissociation constant. ka, association rate constant. kd, dissociation rate constant. 
 
 
System Temp.  
[oC] 
KA,1  
[M-1] 
log 
KA,1 
KD,1  
[nM] 
ka,1  
[M-1s-1] 
kd,1  
[s-1] 
KA,2  
[M-1] 
log 
KA,2 
KD,2 
[nM] 
ka,2  
[M-1s-1] 
kd,2  
[s-1] 
 
QCM 37 1.00·108 8.00 10.00 5.54·105 5.54·10-3 6.38·107 7.80 15.67 5.15·104 8.07·10-4 
CE 37 4.94·107 7.69 20.24 ND ND ND ND ND ND ND 
